NCT07135427View on ClinicalTrials.gov

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

June 30, 2027

Conditions
Alpha 1-AntitrypsinCOPDAntibody Deficiency
Interventions
BIOLOGICAL

20-valent pneumococcal conjugate vaccine

Administration of PCV20

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (1)

Alpha-1 Foundation
All Listed Sponsors
collaborator

Alpha-1 Foundation

OTHER

lead

University of Alabama at Birmingham

OTHER